Symptomatic circumscribed choroidal hemangioma undergoing PDT: VA outcomes.
OBJECTIVE
To report visual acuity (VA) outcomes in eyes undergoing photodynamic therapy (PDT), with or without concurrent intravitreal Triamcinolone acetonide (IVTA), for symptomatic circumscribed choroidal hemangioma.


METHODS
We retrospectively reviewed clinical records of 16 patient treated from January 2001 to May 2006. Post-treatment Snellen VA was compared with pretreatment measurements.


RESULTS
Ten eyes underwent only PDT therapy, in which VA in three eyes improved by more than two lines and seven eyes remained stable. Four eyes were treated with combined PDT and IVTA. VA in two of those eyes improved more than 2 lines, one eye remained stable, and one eye worsened at most recent follow-up. Another two eyes failed initial treatment elsewhere and were not included in the final analysis.


CONCLUSIONS
VA outcome is generally good in patients treated with PDT alone. This study was limited by a small sample size of PDT/IVTA treatment group, therefore, we could not compare outcomes to the PDT alone treatment.
Huang
Shao
S
Bascom Palmer Eye Institute, Miami, Florida, USA. xushao.huang@va.gov
Fabian
James
J
Murray
Timothy
T
Shi
Wei
W
D000328:Adult; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006391:Hemangioma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007267:Injections; D008875:Middle Aged; D010778:Photochemotherapy / Q000009:adverse effects; D012189:Retrospective Studies; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects; D014792:Visual Acuity; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide